AAIC 2025 Abstract
Low‐Dose Interleukin‐2 in Patients with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial
Trial in peopleInterventions
Papers by Nazaret Gamez
2 results
- AAIC 2025 Abstract
Inflammation clinical trial in mild to moderate Alzheimer's disease: TSPO‐PET results
Trial in peopleInterventions